APA

Westin J. R., Thompson M. A., Cataldo V. D., Fayad L. E., Fowler N., Fanale M. A., Neelapu S., Samaniego F., Romaguera J., Shah J., McLaughlin P., Pro B., Kwak L. W., Sanjorjo P., Murphy W. A., Jimenez C., Toth B., Dong W. & Hagemeister F. B. (20131210). Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial. : Clinical lymphoma, myeloma & leukemia.

Chicago

Westin Jason R, Thompson Michael A, Cataldo Vince D, Fayad Luis E, Fowler Nathan, Fanale Michelle A, Neelapu Saatva, Samaniego Felipe, Romaguera Jorge, Shah Jatin, McLaughlin Peter, Pro Barbara, Kwak Larry W, Sanjorjo Perpetua, Murphy William A, Jimenez Camillo, Toth Bela, Dong Wenli and Hagemeister Fredrick B. 20131210. Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial. : Clinical lymphoma, myeloma & leukemia.

Harvard

Westin J. R., Thompson M. A., Cataldo V. D., Fayad L. E., Fowler N., Fanale M. A., Neelapu S., Samaniego F., Romaguera J., Shah J., McLaughlin P., Pro B., Kwak L. W., Sanjorjo P., Murphy W. A., Jimenez C., Toth B., Dong W. and Hagemeister F. B. (20131210). Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial. : Clinical lymphoma, myeloma & leukemia.

MLA

Westin Jason R, Thompson Michael A, Cataldo Vince D, Fayad Luis E, Fowler Nathan, Fanale Michelle A, Neelapu Saatva, Samaniego Felipe, Romaguera Jorge, Shah Jatin, McLaughlin Peter, Pro Barbara, Kwak Larry W, Sanjorjo Perpetua, Murphy William A, Jimenez Camillo, Toth Bela, Dong Wenli and Hagemeister Fredrick B. Zoledronic acid for prevention of bone loss in patients receiving primary therapy for lymphomas: a prospective, randomized controlled phase III trial. : Clinical lymphoma, myeloma & leukemia. 20131210.